medical research

Op-ed by The Honorable John Edward Porter, Research!America Chair and former U.S. Representative (1980 ’€“ 2001) published in McClatchy-Tribune newspapers , including the Great Falls Tribune , News & Observer , Times Herald Record and Billings Gazette . The health of Americans and future generations is at risk. This seems incredulous given our track record in medical discoveries that improved health care and saved lives over the years. But our nation’s research ecosystem is now in a precarious state as a result of federal policies and proposals that continue to undermine medical innovation. Sequestration, the across-the-board spending cuts for federal agencies, is a self-inflicted wound...
Dear Research Advocate: Budget Uncertainty Deepens The House Appropriations Committee has postponed this week’€™s scheduled consideration of the Labor-Health and Human Services (Labor-H) funding measure. A New York Times article indicated that the bill protects NIH funding; but, given how low the overall spending number is for Labor-H, “protected” is most likely interpreted as the NIH being cut less than other agencies, themselves highly valued. The distance between the Senate (passed) and House (estimated) Labor-H appropriations ’€” in excess of 20% ’€” sets the stage for another continuing resolution (CR). What actually does happen next is uncertain, which is why advocacy is essential...
Dear Research Advocate: Budget Uncertainty Deepens The House Appropriations Committee has postponed this week’€™s scheduled consideration of the Labor-Health and Human Services (Labor-H) funding measure. A New York Times article indicated that the bill protects NIH funding; but, given how low the overall spending number is for Labor-H, “protected” is most likely interpreted as the NIH being cut less than other agencies, themselves highly valued. The distance between the Senate (passed) and House (estimated) Labor-H appropriations ’€” in excess of 20% ’€” sets the stage for another continuing resolution (CR). What actually does happen next is uncertain, which is why advocacy is essential...
We NEED CURES, NOT CUTS Sequestration’€™s arbitrary, across-the-board budget cuts to defense and non-defense spending have ravaged (and will continue to ravage) our research enterprise. Sequestration and the inability of Congress to pass a budget will dramatically reduce funding for medical research and critical public health functions for years to come. Funding cuts are stopping highly promising research in its tracks, squandering exciting new potential for treatments and cures for millions of Americans who are waiting for them. We can’€™t let this continue. Deficit reduction is important, but there are ways to achieve it that do not compromise American lives and American competitiveness...
We NEED CURES, NOT CUTS Sequestration’€™s arbitrary, across-the-board budget cuts to defense and non-defense spending have ravaged (and will continue to ravage) our research enterprise. Sequestration and the inability of Congress to pass a budget will dramatically reduce funding for medical research and critical public health functions for years to come. Funding cuts are stopping highly promising research in its tracks, squandering exciting new potential for treatments and cures for millions of Americans who are waiting for them. We can’€™t let this continue. Deficit reduction is important, but there are ways to achieve it that do not compromise American lives and American competitiveness...
Tell Congress to Make it Permanent. The R&D tax credit, a proven engine of economic development, was created more than 30 years ago and spurs innovation by companies of every size across every sector. For medical research and development, the tax credit not only creates jobs, but it enables critical R&D focused on a host of disabling and deadly illnesses. However, as it stands, the tax credit needs to be reauthorized by Congress and the president every year. This creates uncertainty for businesses and hinders the full economic benefit of this incentive. Strengthening the tax credit by making it permanent is vital to continuing our nation’€™s commitment to research. The Senate...
Tell Congress to Make it Permanent. The R&D tax credit, a proven engine of economic development, was created more than 30 years ago and spurs innovation by companies of every size across every sector. For medical research and development, the tax credit not only creates jobs, but it enables critical R&D focused on a host of disabling and deadly illnesses. However, as it stands, the tax credit needs to be reauthorized by Congress and the president every year. This creates uncertainty for businesses and hinders the full economic benefit of this incentive. Strengthening the tax credit by making it permanent is vital to continuing our nation’€™s commitment to research. The Senate...
Dear Research Advocate: Our elected representatives know they must make hard tax and entitlement reform decisions, and, for the sake of the nation, ensure those decisions foster economic growth and societal progress. Part of that equation is federal funding for medical research sufficient to capitalize on unprecedented scientific opportunity and tackle urgent threats like Alzheimer’€™s Disease. As I’€™ve highlighted before, a majority of Americans say they are willing to pay additional taxes ’€” $1 more per week (which amounts to approximately $4.4 billion annually) ’€” if they knew those dollars were funding medical research. The public is on our side with their wallets as well as their...
Dear Research Advocate: Our elected representatives know they must make hard tax and entitlement reform decisions, and, for the sake of the nation, ensure those decisions foster economic growth and societal progress. Part of that equation is federal funding for medical research sufficient to capitalize on unprecedented scientific opportunity and tackle urgent threats like Alzheimer’€™s Disease. As I’€™ve highlighted before, a majority of Americans say they are willing to pay additional taxes ’€” $1 more per week (which amounts to approximately $4.4 billion annually) ’€” if they knew those dollars were funding medical research. The public is on our side with their wallets as well as their...
by Mary Woolley, Research!America President and CEO. This entry was originally posted as a guest contribution to PhRMA’€™s Conversations forum. A shift in attitude among elected officials is necessary if this nation is to succeed in combating disease and stemming the rise of health care costs. Federal funding for the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and other agencies that conduct medical and health research has not kept pace with scientific opportunity, jeopardizing our ability to find cures for deadly disease and to maintain our global competitive edge. Medical research has not risen to the upper ranks of our nation’€™s priorities in the halls...

Pages

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter